Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesDividends payablesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Envoy Medical (COCH) Other Accumulated Expenses (2023 - 2025)

Envoy Medical's Other Accumulated Expenses history spans 3 years, with the latest figure at $13000.0 for Q3 2025.

  • For Q3 2025, Other Accumulated Expenses fell 99.64% year-over-year to $13000.0; the TTM value through Sep 2025 reached $13000.0, down 99.64%, while the annual FY2024 figure was $573000.0, 11.16% down from the prior year.
  • Other Accumulated Expenses for Q3 2025 was $13000.0 at Envoy Medical, down from $179000.0 in the prior quarter.
  • Across five years, Other Accumulated Expenses topped out at $3.6 million in Q3 2024 and bottomed at $13000.0 in Q3 2025.
  • The 3-year median for Other Accumulated Expenses is $415000.0 (2025), against an average of $817857.1.
  • The largest YoY upside for Other Accumulated Expenses was 38.33% in 2025 against a maximum downside of 99.64% in 2025.
  • A 3-year view of Other Accumulated Expenses shows it stood at $645000.0 in 2023, then fell by 11.16% to $573000.0 in 2024, then crashed by 97.73% to $13000.0 in 2025.
  • Per Business Quant, the three most recent readings for COCH's Other Accumulated Expenses are $13000.0 (Q3 2025), $179000.0 (Q2 2025), and $415000.0 (Q1 2025).